| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000012580 |
| Receipt No. | R000014716 |
| Scientific Title | Effects of Kampo medical formula for the blood circulation in the eye with healthy subjects |
| Date of disclosure of the study information | 2013/12/16 |
| Last modified on | 2020/08/04 (Ver. 6) |
| Basic information | ||
| Public title | Effects of Kampo medical formula for the blood circulation in the eye with healthy subjects | |
| Acronym | Effects of Kampo medical formula for the blood circulation in the eye | |
| Scientific Title | Effects of Kampo medical formula for the blood circulation in the eye with healthy subjects | |
| Scientific Title:Acronym | Effects of Kampo medical formula for the blood circulation in the eye | |
| Region |
|
|
| Condition | ||||
| Condition | healthy subjects | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | Evaluate the effects of Kampo medical formula in the eye |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | blood circulation in the eye evaluetad by Laser Speckle Flowgraphy |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | |
| Blinding | Single blind -participants are blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 5 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | yokukansan 5g | |
| Interventions/Control_2 | tokishakuyakusan 5g | |
| Interventions/Control_3 | keishibukuryogan 5g | |
| Interventions/Control_4 | hachimijiogan 5g | |
| Interventions/Control_5 | water | |
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Intra ocular pressure <= 22 mmHg
Without abnormality in funduscopy Without the history of surgery to the eye Without HT or DM Without the history of smoking hanits |
|||
| Key exclusion criteria | Intra ocular pressure => 22 mmHg
Abnormality in funduscopy With the history of surgery to the eye With HT or DM With the history of smoking hanits |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Tohoku University Graduate School of Medicine | ||||||
| Division name | Comprehensive Education Center for Community Medicine | ||||||
| Zip code | 980-8574 | ||||||
| Address | 2-1, Seiryo-machi, Aoba ward, Sendai 980-8575, Japan | ||||||
| TEL | 022-717-8010 | ||||||
| takayama@med.tohoku.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Tohoku University Hospital | ||||||
| Division name | Comprehensive Regional Medical Education Support Department, Kampo Internal Medicine | ||||||
| Zip code | 980-8574 | ||||||
| Address | 1-1, Seiryo-machi, Aoba ward, Sendai 980-8575, Japan | ||||||
| TEL | 022-717-7507 | ||||||
| Homepage URL | |||||||
| akiko.kuwabara.d7@tohoku.ac.jp | |||||||
| Sponsor | |
| Institute | Tohoku university |
| Institute | |
| Department | |
| Funding Source | |
| Organization | JSPS
KAKEN |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Ethics Committee Tohoku University Hospital |
| Address | 1-1, Seiryo-machi, Aoba ward, Sendai |
| Tel | 022-728-4105 |
| ec@rinri.hosp.tohoku.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | http://www.hindawi.com/journals/ecam/2014/586857/ |
| Publication of results | Published |
| Result | |
| URL related to results and publications | http://www.hindawi.com/journals/ecam/2014/586857/ |
| Number of participants that the trial has enrolled | |
| Results | A crossover protocol was used to randomly administer five grams of yokukansan, tokishakuyakusan (TSS), keishibukuryogan, or hachimijiogan to 13 healthy blinded subjects (mean age: 37.3 years). The mean blur rate, a quantitative OBF index obtained with laser speckle flowgraphy, was measured at the optic nerve head before and 30 minutes after administration. Blood pressure (BP) and intraocular pressure (IOP) were also recorded. No significant changes were observed in mean BP or IOP after the administration of any of the kampo medical formulas. There was a significant increase in OBF 30 minutes after administration of TSS (100% to 103.6 %, p < 0.01). Next, TSS was administered to 19 healthy subjects (mean age: 32.0 years) and OBF was measured before and 15, 30, 45, and 60 minutes after administration. Plain water was used as a control. OBF increased significantly after TSS administration compared to control (p < 0.01) and also increased from 30 to 60 minutes after administration compared to baseline (p < 0.05). |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000014716 |